1-naphthylisothiocyanate has been researched along with Hypercholesterolemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groen, AK; Hoekstra, M; van der Geest, R; van der Sluis, RJ; Van Eck, M | 1 |
| Groen, AK; Hoekstra, M; Ouweneel, AB; van der Geest, R; van der Sluis, RJ; Van Eck, M | 1 |
2 other study(ies) available for 1-naphthylisothiocyanate and Hypercholesterolemia
| Article | Year |
|---|---|
Cholestasis-associated glucocorticoid overexposure does not increase atherogenesis.
Topics: 1-Naphthylisothiocyanate; Animals; Apolipoproteins E; Atherosclerosis; Cholestasis; Cholesterol; Corticosterone; Disease Models, Animal; Glucocorticoids; Humans; Hypercholesterolemia; Mice, Inbred C57BL; Mice, Knockout; Risk Factors; Species Specificity | 2019 |
Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice.
Topics: 1-Naphthylisothiocyanate; Adrenalectomy; Animals; Bile Acids and Salts; Cholestasis; Cholesterol; Corticosterone; Hypercholesterolemia; Liver; Liver Diseases; Mice, Inbred C57BL; Mifepristone; Receptors, Cytoplasmic and Nuclear; Receptors, Glucocorticoid | 2016 |